GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (OTCPK:DGNMF) » Definitions » FCF Margin %

DGNMF (Diagnamed Holdings) FCF Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Diagnamed Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Diagnamed Holdings's Free Cash Flow for the three months ended in Jun. 2024 was $-0.15 Mil. Diagnamed Holdings's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, Diagnamed Holdings's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, Diagnamed Holdings's current FCF Yield % is -32.48%.

The historical rank and industry rank for Diagnamed Holdings's FCF Margin % or its related term are showing as below:


DGNMF's FCF Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.43
* Ranked among companies with meaningful FCF Margin % only.


Diagnamed Holdings FCF Margin % Historical Data

The historical data trend for Diagnamed Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings FCF Margin % Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23
FCF Margin %
- - -

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Diagnamed Holdings's FCF Margin %

For the Health Information Services subindustry, Diagnamed Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnamed Holdings's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Diagnamed Holdings's FCF Margin % falls into.



Diagnamed Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Diagnamed Holdings's FCF Margin for the fiscal year that ended in Sep. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-0.789/0
= %

Diagnamed Holdings's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.152/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diagnamed Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Diagnamed Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnamed Holdings Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.